The Beers Criteria was updated in 2019. Of the numerous updates, I wanted to pull out my top 5 clinically relevant Beers Criteria updates. It is important to note that there were many more updates, but I wanted to share some of the most clinically important updates.
Discussed in the video are Beers Criteria updates on sulfonylureas, H2 blockers, opioids, antibiotics, and tramadol.
Hope you enjoy the video and you can find our full-length 35-minute video within our BCGP, BCPS, BCACP, and BCMTMS study material which will be released in October/November timeframe. Purchasing now will give you access to those updates and get you locked in at the lowest price! If you are within your access window, you will automatically get those updates when they become available!
Great Post!
I also found it interesting the Beers recommendation for aspirin use for Primary Prevention:
Due to increased risk for bleeding, it is now recommended to use extra caution in those patients’ ≥70 years of age (decreased from 80 years of age previously) when using aspirin for primary prevention of cardiovascular disease. This recommendation also extends to primary prevention of colorectal cancer. Several studies were evaluated including The Aspirin in Reducing Events in the Elderly (ASPREE) trial and it was determined there was a lack of net benefit when aspirin was used for primary prevention of cardiovascular disease. Notice this recommendation does not extend to the use of aspirin in secondary cardiovascular disease prevention.